Literature DB >> 33068062

Development of an immunogenicity score for HLA-DQ eplets: A conceptual study.

Lara Schawalder1, Gideon Hönger1,2,3, Marc Kleiser3, Michelle R van Heck4, Loes A L van de Pasch4, Sanne Vendelbosch4, Erik H Rozemuller4, Stefan Schaub1,2,3.   

Abstract

Eplets are defined as distinct amino acid configurations on the surface of HLA molecules. The aim of this study was to estimate the immunogenicity of HLA-DQ eplets in a cohort of 221 pregnancies with HLA-DQ mismatches. We defined the immunogenicity of an eplet by the frequency of antibody responses against it. Around 90% of all listed DQB1 or DQA1 eplets were at least five times mismatched and thus included for the calculation of their immunogenicity. The DQB1 eplets with the five highest immunogenicity scores were 55PP, 52PR, 52PQ, 85VG and 45EV; 25% of all DQB1 eplets were not reacting. The DQA1 eplets with the five highest immunogenicity scores were 25YS, 47QL, 55RR, 187T and 18S; 17% of all DQA1 eplets were not reacting. The immunogenicity score had a slightly higher area under the curve to predict development of child-specific antibodies than various molecular mismatch scores (eg, eplet mismatch load, amino acid mismatch load). Overlapping eplets were identified as a barrier to unambiguously assign the immunogenicity score based on HLA antibody reaction patterns. In this conceptual study, we explored the immunogenicity of HLA-DQ eplets and created a map of potentially immunogenic regions on HLA-DQ molecules, which requires validation in clinical transplant cohorts.
© 2020 The Authors. HLA: Immune Response Genetics published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HLA-DQ; eplets; immunogenicity

Mesh:

Substances:

Year:  2020        PMID: 33068062      PMCID: PMC7756751          DOI: 10.1111/tan.14110

Source DB:  PubMed          Journal:  HLA        ISSN: 2059-2302            Impact factor:   4.513


  26 in total

1.  Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.

Authors:  Vasilis Kosmoliaptsis; Linda D Sharples; Afzal N Chaudhry; David J Halsall; J Andrew Bradley; Craig J Taylor
Journal:  Transplantation       Date:  2011-01-27       Impact factor: 4.939

2.  Different eplet software programs give discordant and incorrect results: An analysis of HLAMatchmaker vs Fusion Matchmaker Eplet calling software.

Authors:  Gabriella Tassone; Dianne De Santis; Irena Vukovic; Jonathan Downing; Olga Patricia Martinez; Lloyd J D'Orsogna
Journal:  HLA       Date:  2020-04-26       Impact factor: 4.513

3.  Toward defining the immunogenicity of HLA epitopes: Impact of HLA class I eplets on antibody formation during pregnancy.

Authors:  Gideon Hönger; Matthias Niemann; Lara Schawalder; James Jones; Michelle R van Heck; Loes A L van de Pasch; Sanne Vendelbosch; Erik H Rozemuller; Irene Hösli; Sarah Blümel; Stefan Schaub
Journal:  HLA       Date:  2020-09-10       Impact factor: 4.513

4.  Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28.

Authors:  Marlies K A Dankers; Dave L Roelen; Ellen M W Van Der Meer-Prins; Peter De Lange; Nelleke Korfage; Jacqueline M A Smits; Guido G Persijn; Ken I Welsh; Ilias I N Doxiadis; Frans H J Claas
Journal:  Transplantation       Date:  2003-02-15       Impact factor: 4.939

5.  Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept.

Authors:  I I Doxiadis; J M Smits; G M Schreuder; G G Persijn; H C van Houwelingen; J J van Rood; F H Claas
Journal:  Lancet       Date:  1996-09-28       Impact factor: 79.321

6.  Differential immunogenicity of paternal HLA Class I antigens in pregnant women.

Authors:  Marlies K A Dankers; Dave L Roelen; Nelleke Korfage; Peter de Lange; Marian Witvliet; Lodewijk Sandkuijl; Ilias I N Doxiadis; Frans H J Claas
Journal:  Hum Immunol       Date:  2003-06       Impact factor: 2.850

7.  Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.

Authors:  Vasilis Kosmoliaptsis; Afzal N Chaudhry; Linda D Sharples; David J Halsall; Timothy R Dafforn; J Andrew Bradley; Craig J Taylor
Journal:  Transplantation       Date:  2009-09-27       Impact factor: 4.939

8.  HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity.

Authors:  Chris Wiebe; Vasilis Kosmoliaptsis; Denise Pochinco; Ian W Gibson; Julie Ho; Patricia E Birk; Aviva Goldberg; Martin Karpinski; Jamie Shaw; David N Rush; Peter W Nickerson
Journal:  Am J Transplant       Date:  2018-12-15       Impact factor: 8.086

9.  Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA-DR.

Authors:  Cynthia S M Kramer; Marry E I Franke-van Dijk; Kim H Bakker; Merve Uyar-Mercankaya; Gonca E Karahan; Dave L Roelen; Frans H J Claas; Sebastiaan Heidt
Journal:  Am J Transplant       Date:  2020-05-15       Impact factor: 8.086

10.  Development of an immunogenicity score for HLA-DQ eplets: A conceptual study.

Authors:  Lara Schawalder; Gideon Hönger; Marc Kleiser; Michelle R van Heck; Loes A L van de Pasch; Sanne Vendelbosch; Erik H Rozemuller; Stefan Schaub
Journal:  HLA       Date:  2020-10-28       Impact factor: 4.513

View more
  6 in total

Review 1.  Pediatric Kidney Transplantation-Can We Do Better? The Promise and Limitations of Epitope/Eplet Matching.

Authors:  Olga Charnaya; Daniella Levy Erez; Sandra Amaral; Dimitrios S Monos
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

2.  Development of an immunogenicity score for HLA-DQ eplets: A conceptual study.

Authors:  Lara Schawalder; Gideon Hönger; Marc Kleiser; Michelle R van Heck; Loes A L van de Pasch; Sanne Vendelbosch; Erik H Rozemuller; Stefan Schaub
Journal:  HLA       Date:  2020-10-28       Impact factor: 4.513

3.  Peptides Derived From Mismatched Paternal Human Leukocyte Antigen Predicted to Be Presented by HLA-DRB1, -DRB3/4/5, -DQ, and -DP Induce Child-Specific Antibodies in Pregnant Women.

Authors:  Matthias Niemann; Benedict M Matern; Eric Spierings; Stefan Schaub; Gideon Hönger
Journal:  Front Immunol       Date:  2021-12-21       Impact factor: 7.561

4.  A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.

Authors:  Suzanne Bezstarosti; Kim H Bakker; Cynthia S M Kramer; Johan W de Fijter; Marlies E J Reinders; Arend Mulder; Frans H J Claas; Sebastiaan Heidt
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

5.  On Path to Informing Hierarchy of Eplet Mismatches as Determinants of Kidney Transplant Loss.

Authors:  Hossein Mohammadhassanzadeh; Karim Oualkacha; Wenmin Zhang; William Klement; Amelie Bourdiec; Jennat Lamsatfi; Yang Yi; Bethany Foster; Paul Keown; Howard M Gebel; Frans Claas; Ruth Sapir-Pichhadze
Journal:  Kidney Int Rep       Date:  2021-03-30

6.  HLA-DQ-Specific Recombinant Human Monoclonal Antibodies Allow for In-Depth Analysis of HLA-DQ Epitopes.

Authors:  Suzanne Bezstarosti; Cynthia S M Kramer; Marry E I Franke-van Dijk; Manon Vergunst; Kim H Bakker; Merve Uyar-Mercankaya; Rico Buchli; Dave L Roelen; Johan W de Fijter; Frans H J Claas; Sebastiaan Heidt
Journal:  Front Immunol       Date:  2022-01-07       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.